In the recent February edition of Cardiology today a large data set (meta-analysis) that incorporated over 70,000 people supported the favorable risk-benefit profile for the new anticoagulants compare...Read More
From the HeartWire there was further follow-up of prior data looking at Pradaxa (dabigatran) versus Coumadin (warfarin) in mechanical heart valve patients. It would appear for now at least that the tr...Read More
This recent article demonstrates that the new generation anticoagulants are as effective as our old gold standard but with less bleeding risk. The study compared a new Xa inhibitor with our present s...Read More
This February JAMA article is a very large observational study looking at the health risks of taking even very brief courses of therapy with a drug class called NSAID’s. NSAID...Read More